# Monopar Therapeutics: Form SCHEDULE 13D/A, filed Jan 30, 2026

- Company: [Monopar Therapeutics](/companies/mnpr.md) (CIK 1645469)
- Form: SCHEDULE 13D/A
- Filed: 2026-01-30
- Accepted by EDGAR: Jan 30, 2026, 14:32 ET
- Period: not reported
- Accession: 0001437749-26-002528
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1645469/000143774926002528/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645469/000143774926002528/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1645469/000143774926002528/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jan 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-002528. Last ingested by Listed: Nov 4, 2026, 20:49 ET. No prices; not investment advice.